Loading...
/News/

Red Leaf Medical Enters the Urinary Tract Infection Market Secures exclusive rights to market UROMUNE® in Canada

By | 2017-10-19T12:31:35+00:00 October 19th, 2017|news|

Mississauga, Canada (October 18, 2017) Red Leaf Medical Inc. is pleased to announce that it has signed an exclusive Canadian distribution agreement with Inmunotek, a leading pharmaceutical company based in Spain, to commercialize UROMUNE®, a novel sublingual vaccine for the treatment of recurrent urinary tract infection. Urinary tract infections (UTIs) are one of the most [...]

Red Leaf Medical Ranks No. 233 on the 2017 PROFIT 500

By | 2017-09-14T13:11:51+00:00 September 14th, 2017|news|

Canadian Business unveils 29th annual list of Canada’s Fastest-Growing Companies Red Leaf Medical Ranks in the PROFIT 500 for Third Year in a Row Mississauga, Ontario (September 14, 2017) Canadian Business and PROFIT today ranked Red Leaf Medical Inc. on the 29th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing Companies. The ranking is [...]

Red Leaf Medical introduces Magnetic Black-Star to the Canadian Market

By | 2017-03-28T13:35:00+00:00 March 28th, 2017|news|

Innovative Technology Improves Patient Care Mississauga, Canada (March 14, 2017) Red Leaf Medical Inc. is pleased to announce Health Canada’s approval of Magnetic Black-Star, a novel Double-J (DJ) ureteric stent system. The addition of this innovative product to Red Leaf Medical’s portfolio further strengthens the company’s extensive offering of premium quality medical products and solutions [...]